2023 | Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study | Lin, Wei-Chen; Tai, Wei-Chen; Chang, Chung-Hsin; CHIA-HUNG TU ; Feng, I-Che; MING-JIUM SHIEH ; Chung, Chen-Shuan; Yen, Hsu-Heng; Chou, Jen-Wei; Wong, Jau-Min; Liu, Yu-Hwa; Huang, Tien-Yu; Chuang, Chiao-Hsiung; Tsai, Tzung-Jiun; Chiang, Feng-Fan; Lu, Chien-Yu; Hsu, Wen-Hung; Yu, Fang-Jung; Chao, Te-Hsin; Wu, Deng-Chyang; Ho, Ai-Sheng; Lin, Hung-Hsin; Feng, Chun-Lung; Wu, Keng-Liang; Wong, Ming-Wun; CHIEN-CHIH TUNG ; Lin, Chun-Chi; Chen, Chia-Chang; Hu, Huang-Ming; Lu, Lung-Sheng; Wang, Huann-Sheng; Wu, I-Chen; Kuo, Hsin-Yu; JIA-FENG WU ; Yao Shih, Hsiang; YEN-HSUAN NI ; Tang, Shu-Lun; Chen, Peng-Hsu; SHU-CHEN WEI | Inflammatory bowel diseases | 3 | | |